Table 1.
No. of integration positive samples (total samples) | Integration rate (95% confidence interval) | Total No. of breakpoints detected | No. of breakpoints per sample | |
---|---|---|---|---|
Gastric carcinoma | 10 (39) | 25.6% (13.0 - 42.1%) | 153 | 0 - 118 |
Hodgkin lymphoma | 2 (11) | 18.2% (2.3 - 51.8%) | 8 | 0 - 5 |
NK/T cell lymphoma | 4 (25) | 16.0% (4.5 - 36.1%) | 6 | 0 - 2 |
NPC | 17 (177) | 9.6% (5.7 - 14.9%) | 28 | 0 - 6 |
Nasopharyngitis | 0 (1) | |||
C666-1 cell line | 1 | 2 |